Palleon Pharmaceuticals, a biotech company, has closed $100 million in Series B financing. Matrix Capital Management led the round with participation from SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, AbbVie Ventures and Surveyor Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: